Aurobindo Pharma Limited (AUROPHARMA.BO)
INR 1264.95
(1.37%)
INR 1264.95
(1.37%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 154.68 Billion INR | -13.86% |
| 2022 | 127.17 Billion INR | 1.32% |
| 2021 | 125.51 Billion INR | -10.01% |
| 2020 | 139.46 Billion INR | 12.24% |
| 2019 | 124.25 Billion INR | 25.55% |
| 2018 | 98.96 Billion INR | 10.18% |
| 2017 | 89.81 Billion INR | 14.85% |
| 2016 | 78.2 Billion INR | 11.7% |
| 2015 | 70.01 Billion INR | 12.56% |
| 2014 | 62.2 Billion INR | 48.03% |
| 2013 | 42.02 Billion INR | 61.52% |
| 2012 | 26.01 Billion INR | 40.63% |
| 2011 | 18.49 Billion INR | -7.72% |
| 2010 | 20.04 Billion INR | 11.6% |
| 2009 | 17.96 Billion INR | 16.29% |
| 2008 | 15.44 Billion INR | 43.4% |
| 2007 | 10.77 Billion INR | 32.62% |
| 2006 | 8.12 Billion INR | 38.11% |
| 2005 | 5.88 Billion INR | 79.94% |
| 2004 | 3.26 Billion INR | -45.78% |
| 2003 | 6.02 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 30.18 Billion INR | -3.84% |
| 2023 Q3 | 41.2 Billion INR | 5.28% |
| 2023 Q1 | 36.35 Billion INR | 27.97% |
| 2023 Q2 | 39.13 Billion INR | 7.65% |
| 2023 FY | 109.54 Billion INR | -13.86% |
| 2023 Q4 | 31.38 Billion INR | -23.83% |
| 2022 Q3 | 34.8 Billion INR | 12.07% |
| 2022 Q2 | 31.05 Billion INR | -5.61% |
| 2022 Q1 | 32.9 Billion INR | 26.73% |
| 2022 FY | 127.17 Billion INR | 1.32% |
| 2022 Q4 | 28.41 Billion INR | -18.36% |
| 2021 Q1 | 33.25 Billion INR | 15.63% |
| 2021 Q4 | 25.96 Billion INR | -20.0% |
| 2021 Q3 | 32.45 Billion INR | -4.11% |
| 2021 FY | 125.51 Billion INR | -10.01% |
| 2021 Q2 | 33.84 Billion INR | 1.77% |
| 2020 FY | 139.46 Billion INR | 12.24% |
| 2020 Q3 | 37.8 Billion INR | -2.11% |
| 2020 Q2 | 38.62 Billion INR | 12.67% |
| 2020 Q1 | 34.27 Billion INR | 14.92% |
| 2020 Q4 | 28.75 Billion INR | -23.93% |
| 2019 Q2 | 31.49 Billion INR | 3.0% |
| 2019 Q4 | 29.82 Billion INR | -7.78% |
| 2019 FY | 124.25 Billion INR | 25.55% |
| 2019 Q1 | 30.58 Billion INR | 55.6% |
| 2019 Q3 | 32.34 Billion INR | 2.68% |
| 2018 Q2 | 27.08 Billion INR | 15.6% |
| 2018 Q4 | 19.65 Billion INR | -29.44% |
| 2018 FY | 98.96 Billion INR | 10.18% |
| 2018 Q1 | 23.43 Billion INR | -1.54% |
| 2018 Q3 | 27.85 Billion INR | 2.84% |
| 2017 Q3 | 25.18 Billion INR | -5.6% |
| 2017 FY | 89.81 Billion INR | 14.85% |
| 2017 Q4 | 23.79 Billion INR | -5.52% |
| 2017 Q2 | 26.67 Billion INR | 22.33% |
| 2017 Q1 | 21.8 Billion INR | 1.97% |
| 2016 Q4 | 21.38 Billion INR | -2.62% |
| 2016 Q1 | 21.29 Billion INR | 0.45% |
| 2016 FY | 78.2 Billion INR | 11.7% |
| 2016 Q2 | 21.9 Billion INR | 2.87% |
| 2016 Q3 | 21.96 Billion INR | 0.26% |
| 2015 FY | 70.01 Billion INR | 12.56% |
| 2015 Q4 | 21.2 Billion INR | 8.45% |
| 2015 Q3 | 19.54 Billion INR | 5.49% |
| 2015 Q2 | 18.52 Billion INR | 3.72% |
| 2015 Q1 | 17.86 Billion INR | 23.57% |
| 2014 Q3 | 16.79 Billion INR | 3.89% |
| 2014 Q4 | 14.45 Billion INR | -13.91% |
| 2014 FY | 62.2 Billion INR | 48.03% |
| 2014 Q1 | 15.3 Billion INR | 34.21% |
| 2014 Q2 | 16.16 Billion INR | 5.63% |
| 2013 Q3 | 12.42 Billion INR | 24.95% |
| 2013 FY | 42.02 Billion INR | 61.52% |
| 2013 Q2 | 9.94 Billion INR | 20.67% |
| 2013 Q1 | 8.24 Billion INR | 64.55% |
| 2013 Q4 | 11.4 Billion INR | -8.25% |
| 2012 Q3 | 7.87 Billion INR | 5.91% |
| 2012 Q2 | 7.43 Billion INR | 31.2% |
| 2012 Q4 | 5 Billion INR | -36.42% |
| 2012 FY | 26.01 Billion INR | 40.63% |
| 2012 Q1 | 5.67 Billion INR | 94.6% |
| 2011 Q3 | 5.79 Billion INR | 0.0% |
| 2011 FY | 18.49 Billion INR | -7.72% |
| 2011 Q4 | 2.91 Billion INR | -49.68% |
| 2010 FY | 20.04 Billion INR | 11.6% |
| 2009 FY | 17.96 Billion INR | 16.29% |
| 2008 FY | 15.44 Billion INR | 43.4% |
| 2007 FY | 10.77 Billion INR | 32.62% |
| 2006 FY | 8.12 Billion INR | 38.11% |
| 2005 FY | 5.88 Billion INR | 79.94% |
| 2004 FY | 3.26 Billion INR | -45.78% |
| 2003 FY | 6.02 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Ajanta Pharma Limited | 21.06 Billion INR | -634.347% |
| Amrutanjan Health Care Limited | 1.55 Billion INR | -9837.663% |
| Sigachi Industries Limited | 2 Billion INR | -7625.327% |
| Bal Pharma Limited | 770.19 Million INR | -19983.602% |
| Ind-Swift Laboratories Limited | 6.19 Billion INR | -2397.157% |
| Medico Remedies Limited | 262.14 Million INR | -58906.844% |
| Lasa Supergenerics Limited | 121.02 Million INR | -127705.421% |
| Venus Remedies Limited | 2.18 Billion INR | -6987.142% |
| Sun Pharma Advanced Research Company Limited | -602.4 Million INR | 25777.516% |
| Alpa Laboratories Limited | 188.89 Million INR | -81788.298% |
| Nectar Lifesciences Limited | 2.97 Billion INR | -5104.569% |
| Shilpa Medicare Limited | 3.54 Billion INR | -4261.121% |
| Aarti Drugs Limited | 8.31 Billion INR | -1760.019% |
| Lupin Limited | 123.71 Billion INR | -25.029% |
| Zydus Lifesciences Limited | 125.21 Billion INR | -23.538% |
| Windlas Biotech Limited | 1.33 Billion INR | -11453.847% |
| Suven Life Sciences Limited | -200.79 Million INR | 77134.468% |
| Eris Lifesciences Limited | 10.42 Billion INR | -1383.514% |
| Valiant Laboratories Limited | -60.66 Million INR | 255083.021% |
| J. B. Chemicals & Pharmaceuticals Limited | 22.69 Billion INR | -581.426% |
| Solara Active Pharma Sciences Limited | 861.2 Million INR | -17861.321% |
| Ipca Laboratories Limited | 29.8 Billion INR | -418.898% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -4085.783% |
| Achyut Healthcare Limited | 4.86 Million INR | -3182020.963% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 40.158% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -10409.734% |
| RPG Life Sciences Limited | 2.48 Billion INR | -6129.678% |
| Mankind Pharma Limited | 44.52 Billion INR | -247.439% |
| Laurus Labs Limited | 24.62 Billion INR | -528.279% |
| Piramal Pharma Limited | 24.47 Billion INR | -532.11% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -16313.738% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | -230.821% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | -477.591% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | -123.077% |
| Unichem Laboratories Limited | 4.86 Billion INR | -3079.55% |
| Sequent Scientific Limited | 2.97 Billion INR | -5092.914% |
| Novartis India Limited | 1.32 Billion INR | -11557.465% |
| Wanbury Limited | 1.73 Billion INR | -8837.886% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -3651.458% |
| Wockhardt Limited | 16.24 Billion INR | -852.481% |
| Themis Medicare Limited | 1.5 Billion INR | -10185.424% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -23602.922% |
| Jubilant Pharmova Limited | 19.64 Billion INR | -687.471% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | -1144.133% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 5.455% |
| Divi's Laboratories Limited | 32.44 Billion INR | -376.828% |
| NATCO Pharma Limited | 25.73 Billion INR | -501.037% |
| Gufic Biosciences Limited | 4.16 Billion INR | -3611.465% |
| IOL Chemicals and Pharmaceuticals Limited | 4.58 Billion INR | -3276.766% |
| Ind-Swift Limited | 2.17 Billion INR | -7019.94% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -2575.527% |
| FDC Limited | 8.33 Billion INR | -1755.882% |
| Krebs Biochemicals & Industries Limited | 192.72 Million INR | -80160.109% |
| Granules India Limited | 16.79 Billion INR | -820.771% |
| Medicamen Biotech Limited | 495.49 Million INR | -31117.853% |
| Alkem Laboratories Limited | 52.29 Billion INR | -195.778% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -2385.784% |
| Biofil Chemicals and Pharmaceuticals Limited | 14.57 Million INR | -1060847.07% |
| Brooks Laboratories Limited | 65.62 Million INR | -235625.236% |
| Megasoft Limited | 342.07 Million INR | -45119.53% |
| ZIM Laboratories Limited | 1.26 Billion INR | -12109.684% |
| Strides Pharma Science Limited | 14.38 Billion INR | -975.074% |
| Neuland Laboratories Limited | 8.24 Billion INR | -1775.436% |
| Morepen Laboratories Limited | 6.16 Billion INR | -2410.564% |
| Hikal Limited | 3.14 Billion INR | -4821.38% |
| Indoco Remedies Limited | 6.04 Billion INR | -2460.415% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -2552.608% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -24829.675% |
| Mangalam Drugs & Organics Limited | 703.6 Million INR | -21884.338% |
| Hester Biosciences Limited | 1.27 Billion INR | -12044.851% |